Integral Health Asset Management’s Beam Therapeutics BEAM Stock Holding History

Integral Health Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Hold	300,000	–	–	0.41%	60
2026 Q1	$7.15M	Sell	300,000 -250,000	-45%	-$6.94M	0.34%	70
2025 Q4	$15.2M	Buy	550,000 +150,000	+38%	+$3.83M	0.76%	47
2025 Q3	$9.71M	Sell	400,000 -100,000	-20%	-$1.99M	0.66%	54
2025 Q2	$8.51M	Buy	+500,000	New	+$8.71M	0.78%	37

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Integral Health Asset Management's BEAM Position: Q2 2026 in Review

Integral Health Asset Management held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 300,000 shares worth $10.3M. The position accounts for 0.41% of the portfolio, ranked #60.

Integral Health Asset Management first reported a position in BEAM in Q2 2025 and has held it in 5 quarters since. The position peaked at $15.2M in Q4 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Integral Health Asset Management held 300,000 shares of Beam Therapeutics worth $10.3M as of Q2 2026.
Integral Health Asset Management left its Beam Therapeutics share count unchanged in Q2 2026.
Beam Therapeutics made up 0.41% of Integral Health Asset Management's portfolio in Q2 2026, its #60 holding.
Integral Health Asset Management first reported a position in Beam Therapeutics in Q2 2025 and has held it in 5 quarters since.
Integral Health Asset Management's Beam Therapeutics position peaked at $15.2M in Q4 2025.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.